A variety of studies confirmed that IL-4, IL-5, and IL-13 play a critical role in the induction of inflammation and EoE by IL-33.76 It is therefore postulated that bioagents against these cytokines may present as one of the potential therapeutics for EoE. This evidence concerns the gene IL5 and eosinophilic esophagitis.